Epstein-barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines

Journal of Virology

Volumn 85, Issue 21, 2011, Pages 11255-11264

  Kondo, Satoru ^a   Wakisaka, Naohiro ^a   Muramatsu, Masamichi ^a   Zen, Yoh ^a   Endo, Kazuhira ^a   Murono, Shigeyuki ^a   Sugimoto, Hisashi ^a   Yamaoka, Shoji ^b   Pagano, Joseph S ^c   Yoshizaki, Tomokazu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; HERMES ANTIGEN; LATENT MEMBRANE PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; FEMALE; MOUSE; NASOPHARYNX CANCER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; VIRUS CARCINOGENESIS;

ANTIGENS, CD24; ANTIGENS, CD44; CELL LINE; CELL PROLIFERATION; EPITHELIAL CELLS; HERPESVIRUS 4, HUMAN; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; ONCOGENE PROTEINS, VIRAL; STEM CELLS; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 80055113577     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00188-11     Document Type: Article

References (36)

1. Al-Hajj, M., M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke. 2003. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100:3983-3988.
2. Burkert, J., W. R. Otto, and N. A. Wright. 2008. Side populations of gastrointestinal cancers are not enriched in stem cells. J. Pathol. 214:564-573.
3. Chen, J., et al. 2010. Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma. J. Transl. Med. 8:30.
4. Cheung, S. T., et al. 1999. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int. J. Cancer 83:121-126.
5. Chu, P. G., and L. M. Weiss. 2002. Keratin expression in human tissues and neoplasms. Histopathology 40:403-439.
6. Collins, A. T., P. A. Berry, C. Hyde, M. J. Stower, and N. J. Maitland. 2005. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65:10946-10951.
7. Contreras-Brodin, B. A., et al. 1991. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids. J. Gen. Virol. 72:3025-3033.
8. Dawson, C. W., A. G. Eliopoulos, S. M. Blake, R. Barker, and L. S. Young. 2000. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells. Virology 272:204-217.
9. Goodell, M. A., K. Brose, G. Paradis, A. S. Conner, and R. C. Mulligan. 1996. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183:1797-1806.
10. Goodell, M. A., et al. 1997. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat. Med. 3:1337-1345.
11. Horikawa, T., et al. 2007. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res. 67:1970-1978.
12. Horikawa, T., et al. 2011. Epstein-Barr virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma. Br. J. Cancer 104:1160-1167.
13. Jeter, C. R., et al. 2005. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 209:993-1005.
14. Johnson, R. J., et al. 1998. The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes. J. Virol. 72:4038-4048.
15. Kondo, S., et al. 2007. MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling. J. Virol. 81:1554-1562.
16. Kong, Q. L., et al. 2010. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog. 6:e1000940.
17. Li, C., et al. 2007. Identification of pancreatic cancer stem cells. Cancer Res. 67:1030-1037.
18. Lo, A. K., et al. 2006. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 8:173-180.
19. Mainou, B. A., and N. Raab-Traub. 2006. LMP1 strain variants: biological and molecular properties. J. Virol. 80:6458-6468.
20. Mani, S. A., et al. 2008. The epithelial mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715.
21. Mehl, A. M., et al. 1998. Isolation and analysis of two strongly transforming isoforms of the Epstein-Barr-virus (EBV)-encoded latent membrane protein-1 (LMP1) from a single Hodgkin's lymphoma. Int. J. Cancer 76:194-200.
22. Mei, Y. P., et al. 2005. siRNA targeting LMP1-induced apoptosis in EBVpositive lymphoma cells is associated with inhibition of telomerase activity and expression. Cancer Lett. 232:189-198.
23. Nitta, T., A. Chiba, N. Yamamoto, and S. Yamaoka. 2004. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma. Cell. Signal. 16:1071-1081.
24. Pagano, J. S. 1999. Epstein-Barr virus: the first human tumor virus and its role in cancer. Proc. Assoc. Am. Phys. 111:573-580.
25. - cancer cells are similarly tumorigenic. Cancer Res. 65:6207-6219.
26. + cell population is enriched in tumor-initiating cells. Cancer Res. 67:6796-6805.
27. Ricci-Vitiani, L., et al. 2007. Identification and expansion of human coloncancer-initiating cells. Nature 445:111-115.
28. - breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res. 8:R59.
29. Wakisaka, N., et al. 2004. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. Mol. Cell. Biol. 24: 5223-5234.
30. Wang, D., D. Liebowitz, and E. Kieff. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
31. Wang, J., L. P. Guo, L. Z. Chen, Y. X. Zeng, and S. H. Lu. 2007. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res. 67:3716-3724.
32. Watanabe, K., et al. 2010. Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells. Stem Cells 28:1303-1314.
33. Woodward, W. A., and E. P. Sulman. 2008. Cancer stem cells: markers or biomarkers? Cancer Metastasis Rev. 27:459-470.
34. Yoshizaki, T., N. Wakisaka, and J. S. Pagano. 2005. Epstein-Barr virus, invasion and metastasis, p. 171-196. In E. S. Robertson (ed.), Epstein-Barr virus. Caister Academic Press, Norfolk, United Kingdom.
35. Zen, Y., et al. 2007. Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am. J. Pathol. 170:1750-1762.
36. Zhou, S., et al. 2001. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7:1028-1034.